Melanoma inhibitory activity (MIA) as a serum marker for early detection of post-surgical relapse in melanoma patients: comparison with 5-S-cysteinyldopa-Reference-Cited by-同舟云学术

Melanoma inhibitory activity (MIA) as a serum marker for early detection of post-surgical relapse in melanoma patients: comparison with 5-S-cysteinyldopa

Published:2002-08 Issue:4 Volume:12 Page:319-323
ISSN:0960-8931
Container-title:Melanoma Research
language:en
Short-container-title:Melanoma Research

Author:

Matsushita Y.,Hatta N.,Wakamatsu K.,Takehara K.,Ito S.,Takata M.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Dermatology,Oncology

Reference20 articles.

1. Serological markers for melanoma

2. S100-Beta, Melanoma-Inhibiting Activity, and Lactate Dehydrogenase Discriminate Progressive From Nonprogressive American Joint Committee on Cancer Stage IV Melanoma

3. Are responses to therapy of metastasized malignant melanoma reflected by decreasing serum values of S100β or melanoma inhibitory activity (MIA)?

4. Normal values of urinary excretion and serum concentration of 5-S-cysteinyldopa and 6-hydroxy- 5-methoxyindole-2-carboxylic acid, biochemical markers of melanoma progression

5. Simultaneous measurement of serum 5-S-cysteinyldopa, circulating intercellular adhesion molecule-1 and soluble interleukin-2 receptor levels in Japanese patients with malignant melanoma

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combination of serum 5-S-cysteinyldopa, melanoma inhibitory activity and IL-8 improves the diagnostic accuracy of malignant melanoma compared with individual markers;Medicine;2022-09-02

2. Significance of 5-S-Cysteinyldopa as a Marker for Melanoma;International Journal of Molecular Sciences;2020-01-09

3. Melanoma inhibitory activity in Brazilian patients with cutaneous melanoma;Anais Brasileiros de Dermatologia;2015-06

4. Cutaneous Melanoma Surveillance Counterpoint: Japan;Patient Surveillance After Cancer Treatment;2012-12-20

5. Impact of lymph node metastases on serum level of melanoma inhibitory activity in stage III melanoma patients;The Journal of Dermatology;2011-06